Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches

Zodwa Dlamini
Passer aux renseignements sur les produits

Overcoming Breast Cancer Therapy Resistance: From Mechanisms to Precision and AI-Powered Approaches

Zodwa Dlamini
Date de sortie :
Couverture souple
Prix habituel $291.95
Prix promotionnel $291.95 Prix habituel $0.00
Vente ferme. Aucun retour ni échange.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.

Téléchargement numérique

Accès immédiat à votre bibliothèque Kobo

Livrer à

Avertissez-moi lorsque de retour en stock

Acheter maintenant et ramasser en magasin Bay & Floor

En rupture de stock

Trouver en magasin

En rupture de stock

Trouvé dans : Health, Medical Reference

Obtenez 1460 points plum  et profitez d’un rabais additionnel avec plum. En savoir plus

Afficher tous les renseignements

Aperçu

394 PAGESANGLAIS

Info promotionnelle
  • Date de publication : Jun 04, 2025
  • Langue : anglais
  • Nombre de pages : 394
  • Éditeur : Springer Nature
  • ISBN : 9783031528620
  • Dimensions : 6.1" W x 1.0" L x 9.25" H

Zodwa Dlamini is a Professor of Molecular Oncology and known for her unwavering commitment to advancing precision oncology. At the core of her career is her pivotal role as the Founding Director of the Pan African Cancer Research Institute (PACRI). Additionally, as the Director of the SAMRC Precision Oncology Research Unit (PORU) and a DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), she is fully committed to advancing precision medicine in the battle against cancer. Beyond her institutional leadership, Professor Dlamini also serves as a distinguished member of the American Association for Cancer Research (AACR) Regional Advisory Committee on Sub-Saharan Africa. She additionally guides the AACR Pathology Resources in Africa Advisory Group,actively identifying strategies to address gaps in cancer pathology services across the African continent. Professor Dlamini extends her contributions to the African Organisation for Research and Training in Cancer (AORTIC),where she actively influences the organization's strategic direction and mission as a member of the Research Committee Scientific Advisory Board. Her dedication to advancing cancer research in Africa was honoured with a Special Award from the Council and Executive of the African Society of Morphology and was then admitted as an "Honorary Fellow" of the West African College of Morphologists. Moreover, she is an Overseas Fellow of the Royal Society of Medicine (London), Professional Member of the New York Academy of Sciences (USA) and a member of the Academy of Science of South Africa, highlighting her contributions to the field of Science. Through her multifaceted efforts, Professor Zodwa Dlamini remains steadfast in her commitment to shaping the ever-evolving landscape of cancer research and her journey is driven by an unshakable belief that cancer can be conquered, paving the way for a healthier and more equitable world.


Articles récemment consultés